FHTX financials

Foghorn Therapeutics (FHTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

FHTX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$30.91M–-$86.39M-$74.28M-1.18
2024$22.60M–-$102.68M-$86.62M-1.58
2023$34.16M–-$107.91M-$98.43M-2.34
2022$19.23M–-$117.14M-$108.88M-2.62
2021$1.32M–-$100.73M-$101.32M-2.73
2020$430.00K–-$68.53M-$68.80M-6.23